A Study to Assess the Equivalence Dose Plans & Efficiency Benefits of the UroNAV High Dose Rate (HDR) Brachytherapy Ultrasound Planning System for Treatment of Prostate Cancer


About this study

The purpose of this study is to compare the UroNav-HDR Brachytherapy system with the current standard operating procedure, which uses either Computed Tomography (CT) or Ultrasound (US) imaging for needle reconstruction and radiotherapy treatment planning.     

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Men 
  • Ages 40-85

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lance Mynderse, M.D.

Contact us for the latest status

Contact information:

Justine Buroker M.B.A., CCRP



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions